Van Eck Associates Corp Uro Gen Pharma Ltd. Transaction History

Van Eck Associates Corp

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 10, 2021	SELL	$15.2 - $20.94 $73,400 - $101,119	-4,829 Closed	0 $0
Q1 2021 May 13, 2021	BUY	$17.99 - $26.96 $1,277 - $1,914	71 Added 1.49%	4,829 $94,000
Q4 2020 Feb 09, 2021	SELL	$17.54 - $25.43 $17,504 - $25,379	-998 Reduced 17.34%	4,758 $86,000
Q3 2020 Nov 12, 2020	BUY	$18.81 - $26.42 $2,238 - $3,143	119 Added 2.11%	5,756 $111,000
Q2 2020 Aug 10, 2020	SELL	$16.5 - $29.7 $2,920 - $5,256	-177 Reduced 3.04%	5,637 $147,000

Q1 2020 May 12, 2020	BUY	$13.68 - $34.6 $2,708 - $6,850	198 Added 3.53%	5,814 $104,000
Q4 2019 Feb 13, 2020	SELL	$21.11 - $34.86 $4,559 - $7,529	-216 Reduced 3.7%	5,616 $187,000
Q3 2019 Nov 08, 2019	BUY	$23.83 - $36.44 $452 - $692	19 Added 0.33%	5,832 $139,000
Q2 2019 Aug 07, 2019	BUY	$32.75 - $40.35 $44,048 - $54,270	1,345 Added 30.1%	5,813 $209,000
Q1 2019 May 13, 2019	BUY	$35.47 - $54.55 $3,688 - $5,673	104 Added 2.38%	4,468 $165,000
Q4 2018 Feb 12, 2019	BUY	$38.35 - $50.39 $36,202 - $47,568	944 Added 27.6%	4,364 $188,000
Q3 2018 Nov 13, 2018	BUY	$41.65 - $51.7 $8,163 - $10,133	196 Added 6.08%	3,420 $162,000
Q2 2018 Aug 13, 2018	BUY	$48.35 - $65.33 $9,573 - $12,935	198 Added 6.54%	3,224 $160,000
Q1 2018 May 11, 2018	BUY	$38.64 - $57.54 $7,805 - $11,623	202 Added 7.15%	3,026 $150,000
Q4 2017 Feb 12, 2018	BUY	$27.28 - $43.26 $77,038 - $122,166	2,824	2,824 $105,000

113

24M

46.9K

44.3K

Ticker URGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 22,740,500
Market Cap $373M
Description
UroGen Pharma Ltd., a biotechnology company, engages in the development and commercialization novel solutions for specialty cancers and urothelial diseases. It offers RTGel, a polymeric biocompatible and reverse thermal gelation hydrogel to improve therapeutic profiles of existing drugs; and Jelmyto for pyelocalyceal solution. The company's lead...

Get notified when there are updates to the investment portfolio of Van Eck Associates Corp, based on Form 13F filings with the SEC.

Stay updated on Van Eck Associates Corp with notifications on news.